Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by Tothemoon514on Oct 09, 2018 11:58pm
120 Views
Post# 28770743

ISOL ANNOUNCED ITS INTENTION TO UPLIST TO A MAJOR US EXCHANG

ISOL ANNOUNCED ITS INTENTION TO UPLIST TO A MAJOR US EXCHANGThis Consolidation is being completed with the intention of an up listing to a major exchange in the United States which will give the Issuer access to more US based retail and institutional investors. The up listing will provide the company the ability to maximize growth and capitalize on new Isodiol International, Inc. Page 2 of 3 (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) opportunities from the developments surrounding the FDA’s recent approval and stance on CBD based medicines as well as new opportunities arising from the anticipated approval of the Agricultural Improvement Act of 2018 that is expected to legalize hemp as an agricultural product in the United States.

THIS WAS BACK IN JUNE, WAS IT BS?
Bullboard Posts